The gene SLC6A9 (solute carrier family 6, member 9) encodes the protein sodium- and chloride-dependent glycine transporter 1. The gene is mapped to human chromosome 1p33 and has 14 exons spanning a length of 19.8kb. It is expressed along the length of the crypt-villus axis by enterocytes.
Synonyms: Anti-GlyT-1; Anti-GlyT1; Anti-Sodium- and chloride-dependent glycine transporter 1; Anti-Solute carrier family 6 member 9
Storage: -20C
Application: All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org)and as a result, are supported by the most extensive characterization in the industry. The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige.
Biochem Physiol Actions: The glycine transporter encoded by the gene SLC6A9 (solute carrier family 6, member 9) functions in glycine uptake in the enterocytes. Polymorphisms in this gene have been associated with human essential hypertension.
Legal Information: Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC